Detected ·
LifeMine Therapeutics
$263M—
LifeMine Therapeutics raised a combined $263M, including an oversubscribed Series E led by Milky Way Investments, with participation from Bezos Expeditions, Gates Frontier, RA Capital Management, GV (Google Ventures), GSK, Invus, and ARCH Venture Partners. The funding will accelerate clinical development of LIFE-001, a new treatment approach for the 1.6 million people living with transplanted organs.
- Website
- —
- Amount
- $263 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-11 12:03:01 UTC
- Signal ID
- 9645316b-cc76-482e-a96b-6e2f6e3f875b
As the API returns it
{
"id": "9645316b-cc76-482e-a96b-6e2f6e3f875b",
"created_at": "2026-08-11T12:03:01.868493Z",
"company_name": "LifeMine Therapeutics",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/lifemine-therapeutics",
"event_type": "funding",
"funding_amount": 263000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*LifeMine Therapeutics raised a combined $263M, including an oversubscribed Series E led by Milky Way Investments, with participation from Bezos Expeditions, Gates Frontier, RA Capital Management, GV (Google Ventures), GSK, Invus, and ARCH Venture Partners. The funding will accelerate clinical development of LIFE-001, a new treatment approach for the 1.6 million people living with transplanted organs.*"
}